Search

Displaying results 6481 - 6490 of 10000 in total
  1. Indication

    Impetigo

    go.drugbank.com/conditions/DBCOND0000235
    Drugs: Cefuroxime · Mupirocin · Neomycin · Ozenoxacin
    Synonyms: Impetigo NOS, Impetigo, NOS
  2. Indication

    Leishmaniasis

    go.drugbank.com/conditions/DBCOND0013913
    Drugs: Amphotericin B · Sodium stibogluconate
    Synonyms: Leishmaniasis NOS, Leishmaniasis NOS (disorder)
  3. Indication

    Hepatic abscess

    go.drugbank.com/conditions/DBCOND0025546
    Drugs: Cilastatin · Metronidazole
    Synonyms: Hepatic abscess, NOS, Abscess of liver, NOS
  4. Indication

    Endocrine System Diseases

    go.drugbank.com/conditions/DBCOND0031899
    Drugs: Betamethasone phosphate · Prednisolone phosphate
    Synonyms: Endocrinopathy, NOS, Endocrine disorder NOS
  5. Drug

    Lexibulin

    go.drugbank.com/drugs/DB05147
    Investigational

    CYT997 is an orally available vascular targeting and cytotoxic agent that has proven effective in animal models of a wide range of tumour types including breast, prostate and colon, as well as some leukemias

  6. Drug

    Mupadolimab

    go.drugbank.com/drugs/DB16488
    Investigational

    NCT03454451 focused on advanced cancers (e.g., non-small cell lung cancer, renal cell cancer, colorectal cancer).

  7. Drug

    ISO-1 F-18

    go.drugbank.com/drugs/DB14900
    Investigational

    ISO-1 F-18 is under investigation in clinical trial NCT00968656 (Assessment of Cellular Proliferation in Tumors by Positron Emission Tomography (PET) Using [18F]ISO-1).

  8. Drug

    Digoxigenin

    go.drugbank.com/drugs/DB03671
    Experimental

    Can be obtained by hydrolysis of digoxin or from Digitalis orientalis L. and Digitalis lanata Ehrh.

  9. Drug

    Strontium malonate

    go.drugbank.com/drugs/DB05732
    Investigational

    It is being developed by Osteologix Inc.

  10. Drug

    Psilocybin

    go.drugbank.com/drugs/DB11664
    Investigational

    In November, 2019, it was granted Breakthrough Therapy status by the FDA.